You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antibodies, Monoclonal

Showing 26 - 50 of 7,894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SURvival of SEzary Syndrome Over 1998-2020 Period and Its

Not yet recruiting
  • Sezary Syndrome
  • Cutaneous T Lymphoma
  • Standard of care
  • Paris, France
    Hôpital Saint-Louis, Service de Dermatologie
Jan 24, 2022

COVID-19 Trial in Beijing (BRII-196 and BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196 and BRII-198
  • Placebo
  • Beijing, Beijing, China
    Investigative Site
Mar 1, 2022

Covid19 Trial in Edinburg, Rio Grande City (BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB)

Recruiting
  • Covid19
  • BAMLANIVIMAB
  • +2 more
  • Edinburg, Texas
  • +2 more
Mar 14, 2022

COVID-19 Trial (GamCoviMab)

Not yet recruiting
  • COVID-19
  • (no location specified)
Feb 6, 2023

Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)

Not yet recruiting
  • Nephrotic Syndrome
  • Genova, Italy
    IRCCS G. Gaslini
Jan 19, 2023

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting
  • Infusion Reaction
  • Monoclonal Antibody
  • Montelukast 10 Mg Oral Tablet
  • Clovis, California
    Community Cancer Institute
Nov 8, 2021

COVID-19 Trial in Stony Brook, Memphis (casirivimab+imdevimab)

Terminated
  • COVID-19
  • Stony Brook, New York
  • +1 more
Jul 26, 2022

TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

Recruiting
  • COVID-19
  • casirivimab with imdevimab
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
  • +3 more
Jan 13, 2022

Consistency of PD-L1 Detecting Method Between E1L3N and 22C3

Completed
  • Non Small Cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Nov 20, 2021

    HIV Antibodies Trial run by the NIAID (VRC-HIVMAB091-00-AB, EDP)

    Completed
    • HIV Antibodies
    • VRC-HIVMAB091-00-AB
    • EDP
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 8, 2022

    COVID-19 Trial in China (BRII-196 and BRII-198, Placebo)

    Completed
    • COVID-19
    • BRII-196 and BRII-198
    • Placebo
    • Beijing, Beijing, China
    • +5 more
    Mar 1, 2022

    Squamous Cell Carcinoma antigen2 in Verruca Vulgaris

    Recruiting
    • Verruca Vulgaris
    • Healthy
    • Immunohistochemical staining monoclonal antibodies to SCCA2 (SERPINB4/ SCCA2 antibody)
    • Sohag, Egypt
      Sohag University
    Jun 7, 2022

    HIV/AIDS Trial in Orlando, Boston, Houston (PGT121 + VRC07-523LS, PGT121 + VRC07-523LS + PGDM1400)

    Completed
    • HIV/AIDS
    • PGT121 + VRC07-523LS
    • PGT121 + VRC07-523LS + PGDM1400
    • Orlando, Florida
    • +2 more
    May 6, 2022

    COVID-19; Isolation of Neutralizing Antibodies for Therapeutics

    Active, not recruiting
    • SARS-CoV 2
    • Blood sampling
    • Grenoble, France
      UniversityGrenobleHospital
    Mar 24, 2022

    HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • +2 more
    • Los Angeles, California
    • +13 more
    Dec 19, 2022

    COVID-19 : Neutralizing Human Monoclonal Antibodies Against

    Completed
    • COVID
    • Blood sample
    • Lyon, France
      Hôpital de la Croix-Rousse
    Jun 17, 2021

    Ocrelizumab in Breastmilk

    Active, not recruiting
    • Multiple Sclerosis
    • Clinically Isolated Syndrome
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

    Not yet recruiting
    • Human Immunodeficiency Virus
    • New York, New York
    • +2 more
    Jul 12, 2022

    COVID-19 Trial in United States (casirivimab+imdevimab)

    Active, not recruiting
    • COVID-19
    • Anaheim, California
    • +6 more
    Jan 26, 2022

    Prognostic Value of Protein IMP3 Expression in Cervical Cancer

    Active, not recruiting
    • Cervical Carcinoma
    • immunohistochemical analysis with murine monoclonal antihuman antibodies IMP3
    • (no location specified)
    Jan 5, 2022

    Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

    Recruiting
    • Rheumatoid Arthritis
    • +3 more
      • Barcelona, Spain
        Hospital de la Santa Creu i Sant Pau
      Apr 25, 2022

      Breast Cancer Trial in Besançon (additional blood sample)

      Completed
      • Breast Cancer
      • additional blood sample
      • Besançon, France
        Centre Hospitalier Régional Universitaire
      Apr 15, 2021

      Chronic Migraine Trial (KOS (Intranasal kinetic oscillation stimulation))

      Not yet recruiting
      • Chronic Migraine
      • KOS (Intranasal kinetic oscillation stimulation)
      • (no location specified)
      Apr 14, 2022

      COVID-19 Trial in United States (casirivimab+imdevimab)

      Recruiting
      • COVID-19
      • Anaheim, California
      • +5 more
      Dec 6, 2021

      Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

      Active, not recruiting
      • Kidney Failure, Chronic
      • +6 more
      • Los Angeles, California
        Norko Ammerman
      Mar 25, 2022